Withdrawal-Related Dysphoria as a Moderator of Ibudilast for Alcohol Use Disorder
Phase of Trial: Phase II
Latest Information Update: 06 Sep 2018
Price : $35 *
At a glance
- Drugs Ibudilast (Primary)
- Indications Alcohol withdrawal; Alcoholism
- Focus Therapeutic Use
- 27 Aug 2018 Status changed from not yet recruiting to recruiting.
- 20 Aug 2018 According to a MediciNova media release, the study is funded by the NIH's National Institute on Drug Abuse (NIDA).
- 06 Jul 2018 Planned initiation date changed from 1 Jun 2018 to 1 Jul 2018.